期刊文献+

益气通阳化痰方治疗2型糖尿病合并非酒精性脂肪肝的临床研究 被引量:6

Clinical research of Yiqitongyanghuatan decoction on type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
下载PDF
导出
摘要 目的观察益气通阳化痰方对2型糖尿病合并非酒精性脂肪肝NAFLD的治疗效果。方法将80例确诊为NAFLD的患者按入选顺序随机分成实验组和对照组,每组40例。2组患者均接受基础治疗,实验组在此基础上加服益气通阳化痰方。2组疗程均为3个月。于治疗前后进行疾病活动指数(DAI)评分、肝脏B超检查及血糖、血脂、肝功能、胰岛素抵抗程度、血浆脂联素、瘦素以及游离脂肪酸(FFA)的检测。结果治疗后实验组DAI显著优于对照组。2组患者治疗后血糖、血脂、肝功能以及胰岛素抵抗程度均有一定的改善,但实验组改善程度更加明显。2组患者在治疗后血浆脂联素和瘦素水平升高,FFA降低,但实验组改变程度更加显著。2组患者治疗后NAFLD均有不同程度的逆转,实验组治疗后呈显著逆转,治疗后3个月实验组FLD等级显著低于对照组。结论益气通阳化痰方可改善NAFLD患者的临床症状、脂肪肝分度、肝功能、血糖、血脂及胰岛素抵抗程度。 Objective It is to observe the therapy effect of Yiqitongyanghuatan decoction on type 2 diabetes mellitus com- plicated with non-alcoholic fatty liver disease ( NAFLD). Methods 80 patients with NAFLD were divided into control group and experimental group randomly, each group had 40 cases. They all were treated with basic therapy, the experimental group, in addition to the above treatments, was given Yiqitongyanghuatan decoction. The treatment periods both were 3 months. Liver ultrasound examination, blood glucose, blood lipid and liver function, adiponectin , leptin, free fatty acid(FFA) as well as scoring of the disease activity index (DAI) and evaluation of insulin resistance were carried out for all patients before and after the treatment. Results DAI score of the experimental group was significantly better than that of the control group after treatment (P 〈 O. O1 ). After 3 months, the blood glucose, lipid, liver function, adiponectin, leptin, free fatty acid(FFA) and insulin resistance of the two groups were improved to different degrees, and those of the experimental group improved more significant- ly. The fat liver disease (FLD) degree of two groups was reversed to different degrees after the 3 - month treatment, the FLD degree of the experimental group was significantly improved (P 〈 0.01). The FLD degree of the experimental group was sig- nificantly better than that of the control group after 3 months ( P 〈0. 05). Conclusion Yiqitongyanghuatan decoction can improve the clinical symptoms, FLD degree, blood glucose, blood fat and insulin resistance of patients with NAFLD.
出处 《现代中西医结合杂志》 CAS 2012年第20期2181-2183,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 2型糖尿病 脂肪肝 肝功能 益气通阳化痰方 胰岛素抵抗 type 2 diabetes mellitus fatty liver disease liver function Yiqitongyanghuatan decoction insulin resistance
  • 相关文献

参考文献13

  • 1Brunt EM. Nonalcoholic steatohepatitis[J].Seminars in Liver Disease,2004,(01):3-20. 被引量:1
  • 2World Health Organization. Definition,diagnosis and classifications of diabetes mellitus and its complications.Report of a WHO consultation,Part 1:Diagnosis and classification of diabetes mellitus[R].Geneva:World Health Organization,1999. 被引量:1
  • 3范建高.非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].胃肠病学和肝病学杂志,2010,19(6):483-487. 被引量:409
  • 4Haffner SM,Miettinen H,Stern MP. The homeostasis model in San Antonio heart study[J].Diabetes Care,1997,(07):1087-1092. 被引量:1
  • 5胡昌武,蒋培新,马相奇,王学禧.老年脂肪肝的病因分析[J].实用老年医学,1999,13(1):29-30. 被引量:25
  • 6Loria P,Lonardo A,Targher G. Is liver fat detrimental to vessels? intersections in the pathogenesis of NAFLD and atherosclerosis[J].Clinical Science(London),2008,(01):1-12. 被引量:1
  • 7Marchesini G,Brizi M,Morselli-Labte AM. Association of no-nalcoholic fatty liver disease with insulin resistance[J].J Am J Med,1999,(05):450-455. 被引量:1
  • 8Giannini EG,Testa R,Savarino V. Liver enzyme alteration:a guide for clinicians[J].Canadian Medical Association Journal,2005,(03):367-379. 被引量:1
  • 9Knilght JA. Liver function tests:their role in the diagnosis hepatobiliary diseases[J].Journal of Infusion Nursing,2005,(02):108-117. 被引量:1
  • 10Mojiminiyi OA,Abdella NA,A1 Arouj M. Adiponectin,insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes[J].Int J Obes(Lond),2007,(02):213-220. 被引量:1

二级参考文献8

共引文献432

同被引文献109

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部